AI assisted reader evaluation in acute CT head interpretation (AI-REACT): protocol for a multireader multicase study.
Clinical Decision-Making
Computed tomography
Head & neck imaging
Intracerebral Hemorrhage
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
12 Feb 2024
12 Feb 2024
Historique:
medline:
13
2
2024
pubmed:
13
2
2024
entrez:
12
2
2024
Statut:
epublish
Résumé
A non-contrast CT head scan (NCCTH) is the most common cross-sectional imaging investigation requested in the emergency department. Advances in computer vision have led to development of several artificial intelligence (AI) tools to detect abnormalities on NCCTH. These tools are intended to provide clinical decision support for clinicians, rather than stand-alone diagnostic devices. However, validation studies mostly compare AI performance against radiologists, and there is relative paucity of evidence on the impact of AI assistance on other healthcare staff who review NCCTH in their daily clinical practice. A retrospective data set of 150 NCCTH will be compiled, to include 60 control cases and 90 cases with intracranial haemorrhage, hypodensities suggestive of infarct, midline shift, mass effect or skull fracture. The intracranial haemorrhage cases will be subclassified into extradural, subdural, subarachnoid, intraparenchymal and intraventricular. 30 readers will be recruited across four National Health Service (NHS) trusts including 10 general radiologists, 15 emergency medicine clinicians and 5 CT radiographers of varying experience. Readers will interpret each scan first without, then with, the assistance of the qER EU 2.0 AI tool, with an intervening 2-week washout period. Using a panel of neuroradiologists as ground truth, the stand-alone performance of qER will be assessed, and its impact on the readers' performance will be analysed as change in accuracy (area under the curve), median review time per scan and self-reported diagnostic confidence. Subgroup analyses will be performed by reader professional group, reader seniority, pathological finding, and neuroradiologist-rated difficulty. The study has been approved by the UK Healthcare Research Authority (IRAS 310995, approved 13 December 2022). The use of anonymised retrospective NCCTH has been authorised by Oxford University Hospitals. The results will be presented at relevant conferences and published in a peer-reviewed journal. NCT06018545.
Identifiants
pubmed: 38346874
pii: bmjopen-2023-079824
doi: 10.1136/bmjopen-2023-079824
doi:
Banques de données
ClinicalTrials.gov
['NCT06018545']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e079824Informations de copyright
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: DR, SK and ST are employees of Qure AI. NW declares consultancy fees from InHealth and SM Radiology not related to the current submission. MH declares consultancy fees from Qure AI not related to the current submission. DJL declares an institution grant for additional research activity on a separate product unrelated to the current submission. AN declares another NHSX grant in collaboration with Qure AI for research unrelated to the current submission. SA declares grants from Qure AI for other research activity unrelated to the current submission.